ROKIT HEALTHCARE Inc.
KOSDAQ-listed medical device company with an organ regeneration platform expanding from diabetic foot skin regeneration into cartilage and kidney regeneration.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2012 and listed on KOSDAQ in 2025, ROKIT HEALTHCARE is a company specializing in an organ regeneration platform. It is expanding its skin regeneration platform, centered on diabetic foot treatment, into pressure ulcers, burns, traumatic defects, post-skin-cancer-excision defects, and breast reconstruction, while conducting preclinical, clinical, and joint research in cartilage and kidney regeneration. It has obtained ISO13485 (2019), KGMP (2023), CE MDR (2023), and U.S. FDA (2023) certifications, and has signed skin regeneration platform contracts with LABORATOIRE BENEWMEDICAL and others, and cartilage regeneration platform contracts with Bioethic Pharma S.A and others.
Products & technology
- Skin regeneration platformSkin regeneration treatment for diabetic foot, pressure ulcers, burns, traumatic defects, post-skin-cancer-excision defects, and breast reconstruction
- Cartilage regeneration platformCartilage regeneration treatment
- Kidney regeneration platformKidney regeneration treatment
Regulatory approvals
data.go.kr4 Korean MFDS device approvals · 2020–2023
- MFDSFat separator, filter2023-01-05Product approval · Class 3제허 23-9 호
- MFDSPerimeter, automaticRevoked2021-08-19Product approval · Class 1수신 21-1580 호
- MFDSFat separator, filter2021-03-30Product approval · Class 3제허 21-206 호
- MFDSHuman cell ＆ Tissue culture incubator2020-01-20Product approval · Class 1체외 제신 20-86 호
R&D and key agreements
Source: DART corporate disclosure연골재생 및 신장재생 전임상·임상 공동연구 · 연골, 신장 · 전임상·임상 진행중 · 5-person technology research institute conducting clinical work and organ regeneration protocol development for skin, cartilage, and kidney regeneration
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.
KOSDAQ-listed medical device company producing auto refractors, auto lensmeters, and other ophthalmic equipment.
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.
KOSDAQ-listed manufacturer of diagnostic X-ray imaging systems and core components such as generators and tubes.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.
Established in 2012 and listed on KOSDAQ in 2018, Osteonic manufactures implants for the CMF, Trauma, Sports Medicine, and Spine categories.
Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition